Skip to main content
$1.22 +0.00 (+0.00%)
Market Cap
$88.21M
Shares
72.30M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.22 Open$1.25 Day$1.22–1.27 52W$0.87–2.99 Avg vol 30d824K Short int10.4M · 14.5% float · 9.9d Short vol42% Last earningsMay 11, 2026 DataApr 2021–Jul 2026 Filing10-Q · May 11

Up next

Next earnings call
Oct 3, 2026 Est · unconfirmed · in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 11, 2026

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Sell Momentum Strong Sentiment Bullish Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 20.7 · elevated Equity put/call 0.61
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −11%
below
Price vs 50-day avg −6%
below
RSI (14) 41
neutral
MACD trend Negative
52-week position 16%
mid-range
Momentum
relative strength
Strong
1-month return −17%
trailing
6-month return +12%
trailing
YTD return −2%
this year
Relative strength +6%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Accumulating
10 of 65 funds reported for Jun 30 · net +177.8K sh shares · +2 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
14.45% of float · ▼ -24.5% MoM · 9.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
65 holders — mid 3-yr range
Squeeze score 61
elevated · 0–100
Fundamentals
Strong
EPS growth +69%
Y/Y
Free cash flow $-70.7M
Balance sheet $55.8M
net cash
Quant / Vol
risk profile
Very High
Volatility 90%
annualized · 1-yr
Max drawdown −64%
past year
ATR 6.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−11% Bearish
Price vs 50-day avg
−6% Bearish
RSI (14)
41 Neutral
MACD trend
Negative Bearish
52-week position
16% Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Accumulating
10 of 65 funds reported for Jun 30 · net +177.8K sh shares · +2 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
14.45% of float · ▼ -24.5% MoM · 9.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
65 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1 Now $1 · 16% 52-wk high $3
vs 200-day avg -11% vs 50-day avg -6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings
Metric Latest Period YoY
Cash, Cash Equivalents, and Restricted Cash $45.1M Q1 2026

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BMEA
Biomea Fusion, Inc.
this stock
$88.21M -1.6% 14.5%
ONC
BeOne Medicines Ltd.
$472.90B +7.7% +22179.2% 962.4 0.1%
VRTX
Vertex Pharmaceuticals Inc / Ma
$122.67B +6.6% +46.2% 28.7 2.0%
REGN
Regeneron Pharmaceuticals, Inc.
$72.91B -9.8% +20.8% 17.5 3.4%
ARGX
Argenx SE
$55.21B +4.9% 2.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
67
% held
34.7%
Reported
10 of 65
Top holder
FMR LLC
Held Float
View
Held by Funds
Fund positions
25
View
Short & Settlement
Short Interest Falling
Shares short
10.4M
Days to cover
9.9d
Change
-3.4M sh
View
Short Volume
Short vol %
42%
As of
Jul 29, 2026
Short Total
View
Fails to Deliver
FTD shares
307
Value
$408
As of
Jul 14, 2026
View
Off-Exchange
Off-exchange %
57.6%
Week of
May 4, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$-61.8M
EPS diluted
$-1.18
View
Filings
SEC Filings
Latest
Investor Event Transcript
Filed
Jun 30, 2026
This year
11
View
Proposed Sales
Value
$48.2M
Shares
1.5M
Filed
May 19, 2023
View
Exempt Offerings
Offering
$56.0M
Filed
Jan 15, 2021
View
Earnings & Events
Earnings Calls
Last call
Jun 4, 2026
View

Performance

5D 20D 120D MTD YTD
BMEA -5.4% -17.0% +11.9% -17.0% -1.6%
SPY -2.4% -2.3% +6.3% -2.3% +7.0%
vs SPY -3.0% -14.7% +5.6% -14.7% -8.6%
Key facts CIK 1840439 CUSIP 09077A106 13F (30d) 10 filings 10 filers Visit website Investor relations